ARCT Arcturus Therapeutics Holdings Inc.

Fundamentals / CIK 0001768224 / USD

Arcturus Therapeutics Holdings Inc. reported $30.51M in revenue and a net loss of $87.24M for the trailing twelve months ended September 30, 2026 (up 6.7% year over year), with a -311.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ARCT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$224.5M$112.3M$0-$207.9MFY 2018 Revenue: $15.75MFY 2018 Net Income: -$21.79M2018FY 2019 Revenue: $20.79MFY 2019 Net Income: -$25.99M2019FY 2020 Revenue: $9.54MFY 2020 Net Income: -$72.15M2020FY 2021 Revenue: $12.36MFY 2021 Net Income: -$203.7M2021FY 2022 Revenue: $206.0MFY 2022 Net Income: $9.35M2022FY 2023 Revenue: $166.8MFY 2023 Net Income: -$29.73M2023FY 2024 Revenue: $152.3MFY 2024 Net Income: -$80.94M2024FY 2025 Revenue: $82.03MFY 2025 Net Income: -$65.78M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $82.03M $152.3M $166.8M $206.0M $12.36M $9.54M $20.79M $15.75M
Research & Development $112.2M $195.2M $192.1M $147.8M $173.8M $57.85M $33.64M $16.98M
Total Operating Expenses $158.3M $248.0M $245.0M $193.8M $215.2M $81.06M $46.30M $37.56M
Operating Income -$76.26M -$95.67M -$78.20M $12.18M -$202.9M -$71.52M -$25.51M -$21.81M
EBITDA -$73.23M -$92.12M -$75.25M $13.70M -$201.7M -$70.64M -$24.83M -$21.23M
Income Before Tax -$65.78M -$80.94M -$27.89M $10.64M -$203.7M -$72.15M -$25.99M -$21.79M
Income Tax Expense -- -$4.0K $1.83M $1.29M -- -- -- --
Net Income -$65.78M -$80.94M -$29.73M $9.35M -$203.7M -$72.15M -$25.99M -$21.79M
Basic EPS -$2.40 -$3.00 -$1.12 $0.35 -$7.74 -$3.55 -$2.15 -$2.16
Diluted EPS -$2.40 -$3.00 -$1.12 $0.35 -$7.74 -$3.55 -$2.15 -$2.16
Basic Shares Outstanding 27.4M 27.0M 26.6M 26.4M 26.3M 20.3M 12.1M 10.1M
Diluted Shares Outstanding 27.4M 27.0M 26.6M 27.1M 26.3M 20.3M 12.1M 10.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $18.30M $2.96M $2.06M $7.20M $17.15M $28.30M $29.38M $22.77M
Research & Development $17.00M $17.52M $21.53M $24.48M $23.27M $29.58M $34.89M $43.78M
Total Operating Expenses $27.48M $28.50M $30.99M $38.50M $33.66M $39.92M $46.21M $56.16M
Operating Income -$9.19M -$25.55M -$28.93M -$31.31M -$16.51M -$11.62M -$16.83M -$33.39M
EBITDA -$8.59M -$24.95M -$28.27M -$30.62M -$15.71M -$10.82M -$16.02M -$32.58M
Income Before Tax -$7.41M -$23.79M -- -$29.08M -$13.45M -$9.18M -$14.08M -$30.01M
Income Tax Expense $0 $0 -- -- $0 $4.0K $0 -$4.0K
Net Income -$7.41M -$23.79M -$26.96M -$29.08M -$13.45M -$9.18M -$14.08M -$30.00M
Basic EPS -$0.26 -$0.84 -$0.95 -- -$0.49 -$0.34 -$0.52 --
Diluted EPS -$0.26 -$0.84 -$0.95 -- -$0.49 -$0.34 -$0.52 --
Basic Shares Outstanding 28.4M 28.4M 28.4M -- 27.2M 27.1M 27.1M --
Diluted Shares Outstanding 28.4M 28.4M 28.4M -- 27.2M 27.1M 27.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $230.9M $237.0M $292.0M $391.9M $370.5M $462.9M $71.35M $36.71M
Cash & Short-Term Investments $230.9M $237.0M $292.0M $391.9M $370.5M $462.9M $71.35M $36.71M
Accounts Receivable, Net $5.56M $3.97M $32.06M $2.76M $3.37M $2.12M $2.18M $4.48M
Other Current Assets -- -- -- -- -- -- $38K $92K
Total Current Assets $241.4M $306.0M $386.6M $403.3M $379.0M $467.8M $74.29M $41.83M
Property, Plant & Equipment, Net $6.74M $9.53M $12.43M $12.41M $5.64M $3.38M $2.35M $1.98M
Total Non-Current Assets $29.70M $38.09M $42.81M $47.05M $13.85M $8.67M $7.85M $2.37M
Total Assets $271.1M $344.1M $429.4M $450.4M $392.8M $476.5M $82.14M $44.20M
Accounts Payable $4.24M $7.19M $5.28M $7.45M $10.06M $10.77M $5.79M $2.40M
Short-Term Debt -- -- -- $60.66M $22.47M $1.25M -- --
Deferred Revenue (Current) $8.25M $19.51M $44.83M $28.65M $43.48M $18.11M $8.40M $6.27M
Total Current Liabilities $36.38M $65.49M $81.99M $127.0M $99.54M $49.52M $21.32M $12.58M
Long-Term Debt -- -- -- -- $40.63M $13.85M $14.99M $9.91M
Deferred Revenue (Non-Current) -- $12.60M $42.50M $20.07M $19.93M $12.51M $15.18M $7.53M
Other Non-Current Liabilities -- -- $497K $2.80M -- -- -- --
Total Non-Current Liabilities $20.78M $37.60M $68.90M $53.09M $65.07M $30.38M $35.03M $17.98M
Total Liabilities $57.16M $103.1M $150.9M $180.1M $164.6M $79.90M $56.35M $30.56M
Total Debt (incl. Leases) $25.00M $28.55M $30.22M $94.75M $69.15M $20.75M $20.67M $9.91M
Common Stock $28K $27K $27K $27K $26K $26K $15K $214K
Retained Earnings -$514.6M -$448.8M -$367.9M -$338.1M -$347.5M -$143.8M -$71.67M -$44.87M
Total Stockholders' Equity $214.0M $241.0M $278.5M $270.3M $228.2M $396.6M $25.79M $13.64M
Total Equity $214.0M $241.0M $278.5M $270.3M $228.2M $396.6M $25.79M $13.64M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $184.8M $191.5M $211.4M $230.9M $180.4M $196.5M $216.9M $237.0M
Cash & Short-Term Investments $184.8M $191.5M $211.4M $230.9M $180.4M $196.5M $216.9M $237.0M
Accounts Receivable, Net $1.25M $1.81M $1.34M $5.56M $7.95M $17.20M $14.57M $3.97M
Total Current Assets $189.4M $197.2M $216.9M $241.4M $249.2M $274.5M $278.8M $306.0M
Property, Plant & Equipment, Net $4.81M $5.36M $6.08M $6.74M $7.42M $8.09M $8.87M $9.53M
Total Non-Current Assets $25.92M $27.15M $28.53M $29.70M $33.14M $34.77M $52.99M $38.09M
Total Assets $215.3M $224.3M $245.4M $271.1M $282.3M $309.3M $331.8M $344.1M
Accounts Payable $5.77M $4.41M $4.09M $4.24M $5.49M $10.62M $6.18M $7.19M
Deferred Revenue (Current) $419K $6.28M $7.61M $8.25M $6.83M $11.26M $12.67M $19.51M
Total Current Liabilities $28.34M $33.54M $34.37M $36.38M $31.70M $46.52M $49.41M $65.49M
Long-Term Debt -- -- -- -- -- -- $15.00M --
Deferred Revenue (Non-Current) -- -- -- -- $4.22M $8.77M $9.63M $12.60M
Total Non-Current Liabilities $18.24M $18.97M $19.68M $20.78M $26.09M $31.70M $48.62M $37.60M
Total Liabilities $46.59M $52.50M $54.05M $57.16M $57.78M $78.22M $98.03M $103.1M
Total Debt (incl. Leases) $21.86M $22.93M $23.99M $25.00M $25.99M $26.96M $42.66M $28.55M
Common Stock $28K $28K $28K $28K $27K $27K $27K $27K
Retained Earnings -$572.8M -$565.3M -$541.6M -$514.6M -$485.5M -$472.1M -$462.9M -$448.8M
Total Stockholders' Equity $168.7M $171.8M $191.4M $214.0M $224.6M $231.1M $233.8M $241.0M
Total Equity $168.7M $171.8M $191.4M $214.0M $224.6M $231.1M $233.8M $241.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$65.78M -$80.94M -$29.73M $9.35M -$203.7M -$72.15M -$25.99M -$21.79M
Depreciation & Amortization $3.02M $3.54M $2.96M $1.53M $1.19M $882K $684K $582K
Stock-Based Compensation $25.41M $37.99M $34.65M $30.61M $28.91M $6.76M $1.98M $1.26M
Change in Receivables -$1.59M $28.09M -$29.30M $603K -$1.24M $54K $2.30M -$4.00M
Change in Payables -$2.96M $1.92M -$2.24M -$3.11M -$769K $4.81M $3.15M $578K
Operating Cash Flow -$74.27M -$59.75M -$18.10M $31.99M -$135.0M -$42.86M -$6.45M -$20.76M
Capital Expenditure -$230K -$648K -$2.90M -$7.73M -$3.41M -$1.74M -$818K -$1.48M
Free Cash Flow -$74.50M -$60.40M -$21.00M $24.27M -$138.4M -$44.60M -$7.26M -$22.24M
Investing Cash Flow -$230K -$648K -$2.90M -$7.73M -$3.41M -$1.74M -$818K $22.13M
Common Stock Issued $11.69M -- -- -- -- $423.8M $21.28M --
Financing Cash Flow $13.38M $5.42M -$24.09M -$2.86M $48.02M $436.1M $41.91M $10.20M
Net Change in Cash -$61.12M -$54.98M -$45.09M $21.41M -$90.43M $391.5M $34.64M $11.58M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.41M -$23.79M -$26.96M -$29.08M -$13.45M -$9.18M -$14.08M -$30.00M
Depreciation & Amortization $600K $600K $658K $682K $800K $800K $801K $819K
Stock-Based Compensation $4.04M $4.23M $4.33M $6.82M $5.73M $6.20M $6.66M $8.98M
Change in Receivables $564K -$470K $4.22M $2.39M $9.25M -$2.63M -$10.60M $26.23M
Change in Payables $1.35M $321K -$142K -$1.34M -$5.04M $4.44M -$1.01M -$2.94M
Operating Cash Flow -$6.91M -$19.91M -$19.44M -$16.23M -$17.15M -$5.75M -$35.14M -$284K
Capital Expenditure -$52K $0 $0 $88K -$181K $0 -$137K $0
Free Cash Flow -$6.96M -$19.91M -$19.44M -$16.14M -$17.33M -$5.75M -$35.27M -$284K
Investing Cash Flow -$52K $18K $34K $88K -$181K $0 -$137K $0
Financing Cash Flow $291K $0 $16K $11.69M $1.23M -$14.73M $15.20M $134K
Net Change in Cash -$6.67M -$19.89M -$19.39M -$4.45M -$16.11M -$20.48M -$20.08M -$150K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -93.0% -62.8% -46.9% 5.9% -1641.3% -749.8% -122.7% -138.5%
Net Profit Margin -80.2% -53.1% -17.8% 4.5% -1648.0% -756.3% -125.0% -138.3%
Return on Equity (ROE) -30.7% -33.6% -10.7% 3.5% -89.2% -18.2% -100.8% -159.7%
Return on Assets (ROA) -24.3% -23.5% -6.9% 2.1% -51.8% -15.1% -31.6% -49.3%
Current Ratio 6.64x 4.67x 4.72x 3.18x 3.81x 9.45x 3.48x 3.33x
Quick Ratio 6.50x 3.68x 3.95x 3.11x 3.76x 9.39x 3.45x 3.28x
Debt to Equity 0.12x 0.12x 0.11x 0.35x 0.30x 0.05x 0.80x 0.73x
Revenue Growth (YoY) -46.1% -8.7% -19.0% +1566.8% +29.6% -54.1% +32.0% --
Operating Income Growth (YoY) -- -- -742.2% -- -- -- -- --
Net Income Growth (YoY) -- -- -417.9% -- -- -- -- --
EPS Growth (YoY) -- -- -420.0% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -156.6% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -186.5% -- -- -- -- --
5Y Revenue / Share Growth +537.6% +227.5% +300.4% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -311.2% -348.3% -161.5% -93.0% -80.3% -59.4% -57.1% -62.8%
Net Profit Margin -285.9% -317.6% -143.8% -80.2% -68.3% -49.3% -47.5% -53.1%
Return on Equity (ROE) -51.7% -54.3% -41.1% -30.7% -29.7% -26.0% -29.2% -33.6%
Return on Assets (ROA) -40.5% -41.6% -32.1% -24.3% -23.6% -19.5% -20.6% -23.5%
Current Ratio 6.68x 5.88x 6.31x 6.64x 7.86x 5.90x 5.64x 4.67x
Quick Ratio 6.56x 5.76x 6.19x 6.50x 5.94x 4.59x 4.69x 3.68x
Debt to Equity 0.13x 0.13x 0.13x 0.12x 0.12x 0.12x 0.18x 0.12x
Revenue Growth (YoY) +6.7% -89.5% -93.0% -68.4% -58.8% -43.2% -22.7% -26.2%
Source: SEC EDGAR CompanyFacts (CIK 0001768224) · from June 30, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:42 UTC · Open in terminal